Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic considerations for HIV treatment in different ethnicities: an update.

Expert opinion on drug metabolism & toxicology - 1 Nov 2017

Neary M, Owen A

Abstract excerpt

INTRODUCTION: Variations in the human genome sequence sometimes play an important role in pharmacokinetics and/or pharmacodynamics. Previous studies have demonstrated a high degree of variation both between and within different ethnic populations. Areas covered: This review sought to summarize key SNPs in CYP2B6, CYP3A enzymes, CYP2C enzymes, UGT2 enzymes, ABCB1, ABCC2, SLCO1B1, NR1I2, and NR1I3 that have...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Constitutive Androstane Receptor
Share to Ethnicity

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Genome, Human

Share to HIV Infections

Share to Multidrug Resistance-Associated Protein 2

Share to Pharmacogenetics

Source

Identifiers

PMID: 28994310
DOI: 10.1080/17425255.2017.1391214

Genes

ABCB1
ABCC2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic considerations for HIV treatment in different ethnicities: an update.PMID 28994310Read ↗

Pharmacogenetics of CYP2B6, CYP2A6 and UGT2B7 in HIV treatment in African populations: focus on efavirenz and nevirapine.Semantic proximity Read ↗

Pharmacogenetic associations with cytochrome P450 in antiretroviral therapy: what does the future hold?Semantic proximity Read ↗

Pharmacogenetics of antiretroviral drugs for the treatment of HIV-infected patients: An updateSemantic proximity Read ↗

Pharmacogenomics of CYP3A: considerations for HIV treatment.Semantic proximity Read ↗

Pharmacogenetics of anti-HIV drugs.Semantic proximity Read ↗

Prevalence of Cytochrome P450 2B6 Single Nucleotide Polymorphism in an HIV-Positive Cohort in Jos, Nigeria: Implication for HIV Therapy.Semantic proximity Read ↗

Pharmacogenetics of antiretroviral therapy.Semantic proximity Read ↗

The dual role of pharmacogenetics in HIV treatment: mutations and polymorphisms regulating antiretroviral drug resistance and disposition.Semantic proximity Read ↗

Allele and Genotype Frequencies of Cytochrome P450 2B6 516G>T Single Nucleotide Polymorphism in HIV-Negative and HIV-Infected Adult Nigerian Populations.Semantic proximity Read ↗

Differences in genetic variants in lopinavir disposition among HIV-infected Bantu Africans.Semantic proximity Read ↗

Genetic Polymorphisms Affecting the Pharmacokinetics of Antiretroviral DrugsSemantic proximity Read ↗

Clinical Impact of Genetic Variants of Drug Transporters in Different Ethnic Groups within and Across RegionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.